A Open-label Phase 2 Study of ZSP1273 in Otherwise Healthy Children 2-17 Years Old With Influenza A
Latest Information Update: 28 Oct 2024
Price :
$35 *
At a glance
- Drugs Onradivir (Primary)
- Indications Influenza A virus infections
- Focus Pharmacokinetics
- Sponsors Guangdong Raynovent Biotech
- 28 Oct 2024 New trial record